{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:11:49Z","timestamp":1757704309950},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T00:00:00Z","timestamp":1274313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s11916-010-0120-z","type":"journal-article","created":{"date-parts":[[2010,5,19]],"date-time":"2010-05-19T06:59:23Z","timestamp":1274252363000},"page":"256-260","source":"Crossref","is-referenced-by-count":14,"title":["Musculoskeletal Pain Associated With Corticosteroid Therapy in Cancer"],"prefix":"10.1007","volume":"14","author":[{"given":"Deborah A.","family":"Frieze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,20]]},"reference":[{"key":"120_CR1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","volume":"328","author":"RI Fisher","year":"1993","unstructured":"Fisher RI, Gaynor ER, Dahlberg S, et al.: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma. N Engl J Med 1993, 328:1002\u20131006.","journal-title":"N Engl J Med"},{"key":"120_CR2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood-2005-02-0522","volume":"106","author":"M Cavo","year":"2005","unstructured":"Cavo M, Zamagni E, Tosi P, et al.: Superiority of thalidomide and dexamethasone over vincristine-doxorubicin-dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. Blood 2005, 106:35\u201339.","journal-title":"Blood"},{"key":"120_CR3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2796.1998.00408.x","volume":"244","author":"R Eastell","year":"1998","unstructured":"Eastell R, Reid DM, Compston J, et al.: A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998, 244:271\u2013292.","journal-title":"J Intern Med"},{"key":"120_CR4","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1200\/JCO.2005.11.676","volume":"23","author":"G Talamo","year":"2005","unstructured":"Talamo G, Angtuaco E, Walker RC, et al.: Avascular necrosis of femoral and\/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy. J Clin Oncol 2005, 23:5217\u20135223.","journal-title":"J Clin Oncol"},{"key":"120_CR5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1359\/jbmr.1999.14.7.1061","volume":"14","author":"SC Manolagas","year":"1999","unstructured":"Manolagas SC, Weinstein RS: New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999, 14:1061\u20131066.","journal-title":"J Bone Miner Res"},{"key":"120_CR6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00002018-200730100-00005","volume":"30","author":"L Fardet","year":"2007","unstructured":"\u2022 Fardet L, Kassar A, Cabane J, Flahault A: Corticocosteroid-induced adverse events in adults. Drug Saf 2007, 30:861\u2013881. This is a comprehensive review of corticosteroid-induced adverse effects.","journal-title":"Drug Saf"},{"key":"120_CR7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/02770909209044799","volume":"29","author":"JR Hollister","year":"1992","unstructured":"Hollister JR: The untoward effects of steroid treatment on the musculoskeletal system and what to do about them. J Asthma 1992, 29:363\u2013368.","journal-title":"J Asthma"},{"key":"120_CR8","first-page":"CD000952","volume":"2","author":"J Homik","year":"2000","unstructured":"Homik J, Suarez-Almazor ME, Shea B, et al.: Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2000, (2):CD000952.","journal-title":"Cochrane Database Syst Rev"},{"key":"120_CR9","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2003.04.105","volume":"21","author":"LS Rosen","year":"2003","unstructured":"Rosen LS, Gordon D, Tchekmedyian S, et al.: Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial\u2014the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 2003, 21:3150\u20133157.","journal-title":"J Clin Oncol"},{"key":"120_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00685541","volume":"28","author":"M Bower","year":"1991","unstructured":"Bower M, Stein RC, Hedley A, et al.: The use of nasal calcitonin spray in the treatment of hypercalcaemia of malignancy. Cancer Chemother Pharmacol 1991, 28:311\u2013312.","journal-title":"Cancer Chemother Pharmacol"},{"key":"120_CR11","doi-asserted-by":"crossref","unstructured":"O\u2019Brien TJ, Mack GR: Multifocal osteonecrosis after short-term high-dose corticosteroid therapy: a case report. Clin Orthop Relat Res 1992, 279:176\u2013179.","DOI":"10.1097\/00003086-199206000-00022"},{"key":"120_CR12","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2169\/internalmedicine.47.1038","volume":"47","author":"N Yildiz","year":"2008","unstructured":"Yildiz N, Ardic F, Deniz S: Very early onset steroid-induced avascular necrosis of the hip and knee in a patient with idiopathic thrombocytopenic purpura. Intern Med 2008, 47:1989\u20131992.","journal-title":"Intern Med"},{"key":"120_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1081-1206(10)60159-7","volume":"103","author":"D Weldon","year":"2009","unstructured":"Weldon D: The effects of corticosteroids on bone: osteonecrosis (avascular necrosis of the bone). Ann Allergy Asthma Immunol 2009, 103:91\u201397.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"120_CR14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ocl.2009.01.004","volume":"40","author":"M Ajmal","year":"2009","unstructured":"Ajmal M, Matas AJ, Kuskowski M, Cheng EY: Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population? Orthop Clin North Am 2009, 40:235\u2013239.","journal-title":"Orthop Clin North Am"},{"key":"120_CR15","first-page":"747","volume":"88","author":"M Arico","year":"2003","unstructured":"Arico M, Pinta Boccalatte MR, et al.: Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003, 88:747\u2013753.","journal-title":"Haematologica"},{"key":"120_CR16","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2000.18.18.3262","volume":"18","author":"LA Mattano Jr","year":"2000","unstructured":"Mattano LA Jr, Sather HN, Trigg ME, Nachman JB: Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children\u2019s Cancer Study Group. J Clin Oncol 2000, 18:3262\u20133272.","journal-title":"J Clin Oncol"},{"key":"120_CR17","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1200\/JCO.2001.19.12.3066","volume":"19","author":"A Strauss","year":"2001","unstructured":"Strauss A, Su JT, Dalton VM, et al.: Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001, 19:3066\u20133072.","journal-title":"J Clin Oncol"},{"key":"120_CR18","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1002\/cncr.24474","volume":"115","author":"S Campbell","year":"2009","unstructured":"\u2022 Campbell S, Sun CL, Kurian S, et al.: Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 2009, 115:4127\u20134135. This is a valuable study identifying potential predictors of avascular necrosis.","journal-title":"Cancer"},{"key":"120_CR19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00002018-200831050-00001","volume":"31","author":"K Shim","year":"2008","unstructured":"Shim K, MacKenzie MJ, Winquist E: Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review. Drug Saf 2008, 31:359\u2013371.","journal-title":"Drug Saf"},{"key":"120_CR20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/02841869209088268","volume":"31","author":"V Tombolini","year":"1992","unstructured":"Tombolini V, Capua A, Pompili E: Avascular necrosis of the femoral head after treatment of Hodgkin\u2019s disease. Acta Oncol 1992, 31:64\u201365.","journal-title":"Acta Oncol"},{"key":"120_CR21","unstructured":"van den Berkmortel F, de Wit R, de Rooy J, DeMulder P: Osteonecrosis in patients with testicular tumours treated with chemotherapy. Neth J Med 2004, 62:23\u201327. [Published erratum appears in Neth J Med 2004, 62:103.]"},{"key":"120_CR22","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1054\/bjoc.2001.2155","volume":"85","author":"AM Cook","year":"2001","unstructured":"Cook AM, Dzik-Jurasz AS, Padhani AR, et al.: The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours. Br J Cancer 2001, 85:1624\u20131626.","journal-title":"Br J Cancer"},{"key":"120_CR23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11999-007-0044-z","volume":"466","author":"F Zadegan","year":"2008","unstructured":"Zadegan F, Raould A, Bizot P, et al.: Osteonecrosis after allogeneic bone marrow transplantation. Clin Orthop Relat Res 2008, 466:287\u2013293.","journal-title":"Clin Orthop Relat Res"},{"key":"120_CR24","first-page":"137","volume":"50","author":"H Cushing","year":"1932","unstructured":"Cushing H: The basophil adenomas of the pituitary body and their clinical manifestations. Johns Hopkins Med J 1932, 50:137\u2013195.","journal-title":"Johns Hopkins Med J"},{"key":"120_CR25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0248-8663(96)81254-9","volume":"17","author":"P Bielefeld","year":"1996","unstructured":"Bielefeld P: Present status of cortisone myopathy [in French]. Rev Med Interne 1996, 17:255\u2013261.","journal-title":"Rev Med Interne"},{"key":"120_CR26","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1212\/WNL.48.5.1234","volume":"48","author":"RR Batchelor","year":"1997","unstructured":"Batchelor RR, Taylor LP, Thaler HT, et al.: Steroid myopathy in cancer patients. Neurology 1997, 48:1234\u20131238.","journal-title":"Neurology"},{"key":"120_CR27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/thorax.56.4.279","volume":"56","author":"LJ Walsh","year":"2001","unstructured":"Walsh LJ, Wong CA, Oborne J, et al.: Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 2001, 56:279\u2013284.","journal-title":"Thorax"},{"key":"120_CR28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0002-9343(76)90327-2","volume":"61","author":"A Askari","year":"1976","unstructured":"Askari A, Vignos PJ Jr, Moskowitz RW: Steroid myopathy in connective tissue disease. Am J Med 1976, 61:485\u2013492.","journal-title":"Am J Med"},{"key":"120_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0606","volume":"197","author":"O Schakman","year":"2008","unstructured":"\u2022\u2022 Schakman O, Gilson H, Thissen JP: Mechanisms of glucocorticoid-induced myopathy. J Endocrinology 2008, 197:1\u201310. This is an excellent review with a thorough discussion of glucocorticoid-induced myopathy.","journal-title":"J Endocrinology"},{"key":"120_CR30","unstructured":"Lesser GJ, O\u2019Rourke KS: Elevated urinary creatine excretion (% CR) is a marker of steroid-induced myopathy in patients with malignant gliomas (Meeting abstract). Proceedings of the American Society of Clinical Oncology. 1997. Abstract 1442. http:\/\/www.asco.org\/ASCOv2\/Meetings\/Abstracts?&vmview=abst_detail_view&confID=30&abstractID=11867"},{"key":"120_CR31","unstructured":"Lim SS: Corticosteroid induced myopathy. Available at http:\/\/emedicine.medscape.com\/article\/313842-overview . Accessed January 3, 2010."},{"key":"120_CR32","doi-asserted-by":"crossref","unstructured":"Blakeley JO, Peng T, Ye X, Grossman SA : Dose and duration of dexamethasone in patients with high grade gliomas (HGG): relationship to steroid myopathy (SM). American Society of Clinical Oncology Annual Meeting Proceedings Part I. J Clin Oncol 2006, 24(18S):Abstract 18517.","DOI":"10.1200\/jco.2006.24.18_suppl.18517"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-010-0120-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-010-0120-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-010-0120-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T21:09:50Z","timestamp":1711487390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-010-0120-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,20]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["120"],"URL":"https:\/\/doi.org\/10.1007\/s11916-010-0120-z","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,20]]}}}